Pharmacology in the Era of Targeted Therapies: The Case of PI3K Inhibitors

von Toska, Eneda, Baselga, José
Veröffentlicht in Clin Cancer Res (2016)

Targeted therapies for breast cancer

von Higgins, Michaela J., Baselga, José
Veröffentlicht 2011

Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to Therapy

von Scaltriti, Maurizio, Elkabets, Moshe, Baselga, José
Veröffentlicht in Clin Cancer Res (2016)

Deconstructing feedback-signaling networks to improve anticancer therapy with mTORC1 inhibitors

von Carracedo, Arkaitz, Baselga, Jose, Pandolfi, Pier Paolo
Veröffentlicht 2008

Treatment of HER2-Positive Metastatic Breast Cancer

von Swain, Sandra M., Clark, Emma, Baselga, José
Veröffentlicht in N Engl J Med (2015)

Implementing Genome-Driven Oncology

von Hyman, David M., Taylor, Barry S., Baselga, José
Veröffentlicht in Cell (2017)

A view on drug resistance in cancer

von Vasan, Neil, Baselga, José, Hyman, David M.
Veröffentlicht in Nature (2019)

Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism

von Fuentes, Gloria, Scaltriti, Maurizio, Baselga, José, Verma, Chandra S
Veröffentlicht 2011

Advances in the management of HER2-positive early breast cancer

von Baselga, José, Coleman, Robert E., Cortés, Javier, Janni, Wolfgang
Veröffentlicht in Crit Rev Oncol Hematol (2017)

Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs

von Osmanbeyoglu, Hatice U., Toska, Eneda, Chan, Carmen, Baselga, José, Leslie, Christina S.
Veröffentlicht in Nat Commun (2017)

Unconventional Secretion is a Major Contributor of Cancer Cell Line Secretomes

von Villarreal, Laura, Méndez, Olga, Salvans, Cándida, Gregori, Josep, Baselga, José, Villanueva, Josep
Veröffentlicht 2013

The Carboxy-terminal Cysteine of the Tetraspanin L6 Antigen Is Required for Its Interaction with SITAC, a Novel PDZ Protein

von Borrell-Pagès, Maria, Fernández-Larrea, Juan, Borroto, Aldo, Rojo, Federico, Baselga, José, Arribas, Joaquín
Veröffentlicht 2000

The tumor suppressor PTEN and the PDK1 kinase regulate formation of the columnar neural epithelium

von Grego-Bessa, Joaquim, Bloomekatz, Joshua, Castel, Pau, Omelchenko, Tatiana, Baselga, José, Anderson, Kathryn V
Veröffentlicht in eLife (2016)

AKT signaling in ERBB2-amplified breast cancer

von Carmona, F Javier, Montemurro, Filippo, Kannan, Srinivasaraghavan, Rossi, Valentina, Verma, Chandra, Baselga, José, Scaltriti, Maurizio
Veröffentlicht in Pharmacol Ther (2015)

Proteomic Identification of Desmoglein 2 and Activated Leukocyte Cell Adhesion Molecule as Substrates of ADAM17 and ADAM10 by Difference Gel Electrophoresis

von Bech-Serra, Joan J., Santiago-Josefat, Belén, Esselens, Cary, Saftig, Paul, Baselga, José, Arribas, Joaquín, Canals, Francesc
Veröffentlicht 2006

Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation

von Anido, Judit, Scaltriti, Maurizio, Bech Serra, Joan Josep, Josefat, Belén Santiago, Rojo Todo, Federico, Baselga, José, Arribas, Joaquín
Veröffentlicht 2006

Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance

von Wehrenberg-Klee, Eric, Turker, N. Selcan, Heidari, Pedram, Larimer, Benjamin, Juric, Dejan, Baselga, José, Scaltriti, Maurizio, Mahmood, Umar
Veröffentlicht in J Nucl Med (2016)

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-cont...

von Miles, David, Baselga, José, Amadori, Dino, Sunpaweravong, Patrapim, Semiglazov, Vladimir, Knott, Adam, Clark, Emma, Ross, Graham, Swain, Sandra M.
Veröffentlicht 2013

Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial

von Bonner, James, Giralt, Jordi, Harari, Paul, Spencer, Sharon, Schulten, Jeltje, Hossain, Anwar, Chang, Shao-Chun, Chin, Steve, Baselga, José
Veröffentlicht in JAMA Otolaryngol Head Neck Surg (2016)

TARGETING THE MUC1-C ONCOPROTEIN DOWNREGULATES HER2 ACTIVATION AND ABROGATES TRASTUZUMAB RESISTANCE IN BREAST CANCER CELLS

von Raina, Deepak, Uchida, Yasumitsu, Kharbanda, Akriti, Rajabi, Hasan, Panchamoorthy, Govind, Jin, Caining, Kharbanda, Surender, Scaltriti, Maurizio, Baselga, Jose, Kufe, Donald
Veröffentlicht 2013